NCT03257215View on ClinicalTrials.gov

Can Vitamin D Treatment Help Treat Moderate to Severe Atopic Dermatitis in Young Children? the D-Vex Pilot Study

PHASE4TerminatedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

October 16, 2017

Primary Completion Date

January 30, 2025

Study Completion Date

January 30, 2025

Conditions
Atopic Dermatitis
Interventions
DRUG

Stoss vitamin D

A single 1.5 mL dose containing 150,000 IU cholecalciferol (100,000 IU/mL) administered on Day 1 (Solution in Olive Oil B.P. )

DRUG

Daily vitamin D

Daily 0.2 mL dose containing 1000 IU cholecalciferol administered from Day 1 to 90

DRUG

Stoss placebo

A single 1.5 mL dose administered on Day 1

DRUG

Daily placebo

A once daily 0.2 mL dose administered from Day 1 to 90

Trial Locations (1)

3052

Royal Children's Hospital Melbourne, Melbourne

Sponsors
All Listed Sponsors
lead

Murdoch Childrens Research Institute

OTHER

NCT03257215 - Can Vitamin D Treatment Help Treat Moderate to Severe Atopic Dermatitis in Young Children? the D-Vex Pilot Study | Biotech Hunter | Biotech Hunter